abstract |
(57) [Summary]nThe present invention relates to novel compounds and their use as medicinal, diagnostic or pharmacological targets. In particular, the present invention relates to the identification of a partner of the FE65 protein and at least in part to modulate the activity of FE65, in particular its interaction with said partner or FE65 for controlling the intracellular transport of APP or the phenomenon of endocytosis. The use of any compound capable of |